This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bever, C. Articles by Johnson, K. Search for Related Content PubMed Articles by Bever, C., Jr Articles by Johnson, K. Social Bookmarking                         What's this?

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, 21201, USA

L Grattan

Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, 21201, USA

HS Panitch

Neurology and Research Services, Baltimore, VA Medical Center, Baltimore, Maryland 21201, USA

KP Johnson

Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, 21201, USA

The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) for MS consisting of the selective reminding, 10136 spatial recall, symbol digit modalities, paced auditory serial addition (PASAT) and word list generation tests is a sensitive measure of early cognitive impairment in MS patients. We administered it to 19 chronic stable MS patients every 60 days for 120 days to examine variability. The mean coefficient of variation for the tests ranged from 18% to 22%. A significant practice effect was seen in the PASAT results (P<0.05) using the Wilcoxon signed rank test These results suggest that cognitive fluctuations analogous to motor fluctuations may occur in MS patients and that the BRB-N may be useful in clinical trials of agents expected to alter cognitive function in MS patients if test-retest variability and practice effects are taken into account Further study is warranted.

Key Words: psychological testing • cognitive impairment • clinical trials

Multiple Sclerosis, Vol. 1, No. 3, 165-169 (1995)
DOI: 10.1177/135245859500100306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Drake, B. Weinstock-Guttman, S. Morrow, D. Hojnacki, F. Munschauer, and R. Benedict Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test Multiple Sclerosis, February 1, 2010; 16(2): 228 - 237. [Abstract] [PDF]

				X. Montalban, J. Sastre-Garriga, M. Tintore, L. Brieva, F. Aymerich, J. Rio, J. Porcel, C. Borras, C. Nos, and A. Rovira A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis Multiple Sclerosis, October 1, 2009; 15(10): 1195 - 1205. [Abstract] [PDF]

				S Cader, J Palace, and P. Matthews Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis J Psychopharmacol, August 1, 2009; 23(6): 686 - 696. [Abstract] [PDF]

				R. Grabner, F. Popotnig, S. Ropele, C. Neuper, F. Gorani, K. Petrovic, F. Ebner, S. Strasser-Fuchs, F. Fazekas, and C. Enzinger Brain activation patterns elicited by the `Faces Symbol Test' -- a pilot fMRI study Multiple Sclerosis, April 1, 2008; 14(3): 354 - 363. [Abstract] [PDF]

				P. Scherer, I.K. Penner, A. Rohr, H. Boldt, I. Ringel, H. Wilke-Burger, E. Burger-Deinerth, K. Isakowitsch, M. Zimmermann, S. Zahrnt, et al. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study Multiple Sclerosis, April 1, 2007; 13(3): 402 - 411. [Abstract] [PDF]

				M P Amato, E Portaccio, B Goretti, V Zipoli, L Ricchiuti, M F De Caro, F Patti, R Vecchio, S Sorbi, and M Trojano The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population Multiple Sclerosis, November 1, 2006; 12(6): 787 - 793. [Abstract] [PDF]

				M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet How to detect cognitive dysfunction at early stages of multiple sclerosis? Multiple Sclerosis, August 1, 2006; 12(4): 445 - 452. [Abstract] [PDF]

				S. J. Camp, V. L. Stevenson, A. J. Thompson, G. T. Ingle, D. H. Miller, C. Borras, B. Brochet, V. Dousset, M. Falautano, M. Filippi, et al. A longitudinal study of cognition in primary progressive multiple sclerosis Brain, December 1, 2005; 128(12): 2891 - 2898. [Abstract] [Full Text] [PDF]

				M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 519 - 526. [Abstract] [Full Text] [PDF]

				C. Christodoulou, L. B. Krupp, Z. Liang, W. Huang, P. Melville, C. Roque, W. F. Scherl, T. Morgan, W. S. MacAllister, L. Li, et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients Neurology, June 10, 2003; 60(11): 1793 - 1798. [Abstract] [Full Text] [PDF]

				A Achiron and Y Barak Cognitive impairment in probable multiple sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 443 - 446. [Abstract] [Full Text] [PDF]

				L P McKeown, A P Porter-Armstrong, and G D Baxter The needs and experiences of caregivers of individuals with multiple sclerosis: a systematic review Clinical Rehabilitation, March 1, 2003; 17(3): 234 - 248. [Abstract] [PDF]

				R L Aupperle, W W Beatty, F deNAP Shelton, and S T Gontkovsky Three screening batteries to detect cognitive impairment in multiple sclerosis Multiple Sclerosis, October 1, 2002; 8(5): 382 - 389. [Abstract] [PDF]

				E. A. DeSousa, R. H. Albert, and B. Kalman Cognitive impairments in multiple sclerosis: A review American Journal of Alzheimer's Disease and Other Dementias, January 1, 2002; 17(1): 23 - 29. [Abstract] [PDF]

				J B Boringa, R H. Lazeron, I E. Reuling, H J Ader, L E. Pfennings, J Lindeboom, L M. de Sonneville, N F Kalkers, and C H Polman The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice Multiple Sclerosis, August 1, 2001; 7(4): 263 - 267. [Abstract] [PDF]

				J. A. Cohen, G. R. Cutter, J. S. Fischer, A. D. Goodman, F. R. Heidenreich, A. J. Jak, J. E. Kniker, M. F. Kooijmans, J. M. Lull, A. W. Sandrock, et al. Use of the Multiple Sclerosis Functional Composite as an Outcome Measure in a Phase 3 Clinical Trial Arch Neurol, June 1, 2001; 58(6): 961 - 967. [Abstract] [Full Text] [PDF]

				D. Berg, M. Maurer, M. Warmuth-Metz, P. Rieckmann, and G. Becker The Correlation Between Ventricular Diameter Measured by Transcranial Sonography and Clinical Disability and Cognitive Dysfunction in Patients With Multiple Sclerosis Arch Neurol, September 1, 2000; 57(9): 1289 - 1292. [Abstract] [Full Text] [PDF]

				J. A. Cohen, J. S. Fischer, D. M. Bolibrush, A. J. Jak, J. E. Kniker, L. A. Mertz, T. T. Skaramagas, and G. R. Cutter Intrarater and interrater reliability of the MS functional composite outcome measure Neurology, February 22, 2000; 54(4): 802 - 806. [Abstract] [Full Text] [PDF]

				J S Fischer, R A Rudick, G R Cutter, S C Reingold, and National MS Society Clinical Outcomes Assessment T The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment Multiple Sclerosis, August 1, 1999; 5(4): 244 - 250. [Abstract] [PDF]

				M. J. Hohol, C. R. G. Guttmann, J. Orav, G. A. Mackin, R. Kikinis, S. J. Khoury, F. A. Jolesz, and H. L. Weiner Serial Neuropsychological Assessment and Magnetic Resonance Imaging Analysis in Multiple Sclerosis Arch Neurol, August 1, 1997; 54(8): 1018 - 1025. [Abstract] [PDF]